IDEAYA Announces First-Patient-In for Company-Sponsored Phase 2 Clinical Trial Evaluating Darovasertib in (Neo)Adjuvant Uveal Melanoma. The Cancer & Hematology Centers is proud to spotlight Sreenivasa R. Chandana, MD, PhD as the investigator for this Phase 2 Trial. Read Full Article
Founded in 1979, CHC has grown to become the largest physician-owned oncology and hematology practice in Michigan. We deliver advanced care in a personal way, and our expertise and caring approach make us dedicated to the help, healing and hope for cancer patients and their families.
Marketing Coordinator, email@example.com